home / United States / Rigel Pharmaceuticals

Rigel Pharmaceuticals Market Cap

$0.30 B

-2.97 M

NASDAQ:RIGL · April 16, 2025

Share price

$17.04

Enterprise Value

$0.33 B

Change (1-Year)

93.3%

Global Rank

#6502

Country Rank

#2474

Regions

USA

Market cap

As of April 16, 2025, Rigel Pharmaceuticals (RIGL) has a market cap of $0.30 billion USD. According to our data, Rigel Pharmaceuticals is ranked No.6502 in global market value.

Sector Rank:

Biotech #383 Pharmaceuticals #352

RIGL Market Capitalization Growth

1 Years Growth:

93.3%

3 Years Growth:

-24.7%

5 Years Growth:

29.3%

10 Years Growth:

-47.5%

15 Years Growth:

-73.3%

20 Years Growth:

-85.7%

Total Growth:

-96%

Rigel Pharmaceuticals Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Rigel Pharmaceuticals Market Cap CAGR Chart

Rigel Pharmaceuticals Market Cap History 2000 - 2025

Year	Market Cap	%Change
Apr 16, 2025	$0.30 B	2.76%
Dec 31, 2024	$0.30 B	16.00%
Dec 29, 2023	$0.26 B	-3.33%
Dec 30, 2022	$0.26 B	-43.40%
Dec 31, 2021	$0.47 B	-24.29%
Dec 31, 2020	$0.62 B	63.55%
Dec 31, 2019	$0.38 B	-6.96%
Dec 31, 2018	$0.41 B	-40.72%
Dec 29, 2017	$0.68 B	63.03%
Dec 30, 2016	$0.42 B	-21.45%
Dec 31, 2015	$0.53 B	33.48%
Dec 31, 2014	$0.40 B	-20.35%
Dec 31, 2013	$0.50 B	-56.15%
Dec 31, 2012	$1.14 B	-17.62%
Dec 30, 2011	$1.39 B	4.78%
Dec 31, 2010	$1.33 B	-20.82%
Dec 31, 2009	$1.68 B	18.87%
Dec 31, 2008	$1.41 B	-68.49%
Dec 31, 2007	$4.47 B	113.90%
Dec 29, 2006	$2.09 B	41.99%
Dec 30, 2005	$1.47 B	-65.77%
Dec 31, 2004	$4.30 B	27.19%
Dec 31, 2003	$3.38 B	93.94%
Dec 31, 2002	$1.74 B	-76.34%
Dec 31, 2001	$7.37 B	-53.50%
Dec 29, 2000	$15.85 B	100%

Similar Companies to Rigel Pharmaceuticals

Name	Market Cap	Market cap difference	Regions
Gilead Sciences GILD	$131.74 B	-0.002 M	USA
Amgen AMGN	$158.77 B	0.132 B	USA
Biogen BIIB	$17.12 B	0.000 M	USA
Vertex Pharmaceuticals VRTX	$128.67 B	-0.003 M	USA
Regeneron Pharmaceuticals REGN	$60.99 B	1.014 B	USA
Incyte INCY	$11.31 B	0.000 M	USA
BioMarin Pharmaceutical BMRN	$11.51 B	-0.000 M	USA
Alnylam Pharmaceuticals ALNY	$29.89 B	-0.001 M	USA
Sarepta Therapeutics SRPT	$5.28 B	-0.000 M	USA
Ionis Pharmaceuticals IONS	$4.51 B	0.000 M	USA
Blueprint Medicines BPMC	$5.21 B	0.000 M	USA
Ultragenyx RARE	$3.32 B	0.000 M	USA

About Rigel Pharmaceuticals Inc.

Name

Rigel Pharmaceuticals, Inc.

Website

https://www.rigel.com

Headquarters

South San Francisco,CA

symbol

RIGL

CURRENCY

USD

country

United States

fullTimeEmployees

162

exchange

NMS

firstTradeDateEpochUtc

1969/12/31

RIGL Market Cap Formula

Market Cap	=	RIGL Stock Price	*	RIGL Shares Outstanding
	=	$17.04	*	17.87 M
	=	$0.30 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe